<DOC>
	<DOCNO>NCT02762604</DOCNO>
	<brief_summary>The investigator propose single-blind randomized clinical trial determine senior show improve mobility ( walk speed ) cognition follow motor imagery ( imagined walking ) training . They hypothesize imagined walking use rehabilitative tool improve walk speed cognition elderly , engage strengthens similar neural system actual walk cognition .</brief_summary>
	<brief_title>Motor Imagery Intervention Improving Gait Cognition Elderly</brief_title>
	<detailed_description>The propose research aim establish efficacy imagined gait protocol improve gait cognition elderly . This imagined gait protocol involve imagined gait single ( imagined walking ; iW ) dual-task ( imagined walk talk ; iWWT ) situation . A single-blind randomized clinical trial 58 cognitively-healthy elderly pre-post measure gait , cognition , functional Magnetic Resonance Imaging ( fMRI ) imagine gait propose . The overall hypothesis imagine gait use rehabilitative tool improve gait cognition elderly engage strengthens similar neural system actual gait cognition . The first aim study establish efficacy imagined gait protocol improve gait cognition elderly . We predict imagined gait intervention improve gait velocity actual walk walking-while-talking condition great extent active control ( visual imagery ) intervention . We also predict imagined gait intervention cognitive performance dual-task walking condition . The second aim study determine neuroplasticity change response imagine gait protocol . We predict neural system engage imagined gait change follow imagined gait intervention .</detailed_description>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<criteria>Adults 65 85 year old , reside community . Able speak English level sufficient undergo study procedure . Plan area next 3 month . Presence dementia ( telephonebased memory impairment screen &lt; 5 AD8 score &gt; 1 . Presence gait disorder diagnose clinician ( e.g . neuropathy ) . Any medical condition chronic medication use ( e.g . neuroleptic ) compromise safety affect cognitive functioning . Terminal illness life expectancy &lt; 12 month . Progressive , degenerative neurologic disease ( e.g . Parkinson 's disease , ALS ) . Major psychiatric disorder Schizophrenia . Pacemaker permanent metal implant like hip prosthesis ( tooth filling ) claustrophobia .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>